FDA delays verdict on Beren’s rare disease drug by three months
Beren Therapeutics is seeking approval in Neimann-Pick disease type C, an application the FDA was set to decide on by August 17. The new target action date is November 17.
FDA delays verdict on Beren’s rare disease drug by three months Read More »
